Skip to main content

and
  1. Article

    Open Access

    Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes

    We recently demonstrated that treatment with sodium-glucose cotransporter-2 inhibitors (SGLT-2i) leads to an increase in myocardial flow reserve in patients with type 2 diabetes (T2D) with stable coronary arte...

    Francesca Cinti, Lucia Leccisotti, Gian Pio Sorice in Cardiovascular Diabetology (2023)

  2. Article

    Open Access

    Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report

    Cardiovascular (CV) outcome trials have shown that in patients with type 2 diabetes (T2D), treatment with sodium-glucose cotransporter-2 inhibitors (SGLT-2i) reduces CV mortality and hospital admission rates f...

    Lucia Leccisotti, Francesca Cinti, Gian Pio Sorice in Cardiovascular Diabetology (2022)

  3. No Access

    Article

    Leptin resistance before and after obesity: evidence that tissue glucose uptake underlies adipocyte enlargement and liver steatosis/steatohepatitis in Zucker rats from early-life stages

    Leptin resistance occurs in obese patients, but its independent contribution to adiposity and the accompanying metabolic diseases, i.e., diabetes, liver steatosis, and steatohepatitis, remains to be establishe...

    Maria Angela Guzzardi, Letizia Guiducci in International Journal of Obesity (2022)

  4. No Access

    Article

    Obesity-related gut hormones and cancer: novel insight into the pathophysiology

    The number of cancers attributed to obesity is increasing over time. The mechanisms classically implicated in cancer pathogenesis and progression in patients with obesity involve adiposity-related alteration o...

    Maria Angela Guzzardi, Gabriella Pugliese in International Journal of Obesity (2021)

  5. Article

    Open Access

    Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial

    Sodium-glucose co-transporter-2 (SGLT-2) inhibitors have been shown to have beneficial effects on various cardiovascular (CV) outcomes in patients with type 2 diabetes (T2D) in primary prevention and in those ...

    Gian Pio Sorice, Francesca Cinti, Lucia Leccisotti, Domenico D’Amario in Diabetes Therapy (2021)

  6. No Access

    Article

    Healthy diets and telomere length and attrition during a 10-year follow-up

    Telomeres are repeats of DNA that contain the sequence TTAGGG at the ends of each chromosome, and their function is to protect DNA from damage. Little evidence exists regarding the relationship between dietary...

    Jelena Meinilä, Mia-Maria Perälä in European Journal of Clinical Nutrition (2019)

  7. Article

    Open Access

    Microbiota signatures relating to reduced memory and exploratory behaviour in the offspring of overweight mothers in a murine model

    An elevated number of women of reproductive age are overweight, predisposing their offspring to metabolic and neuropsychiatric disorders. Gut microbiota is influenced by maternal factors, and has been implicat...

    Elena Sanguinetti, Maria Angela Guzzardi, Maria Tripodi in Scientific Reports (2019)

  8. Article

    Open Access

    Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: an in vitro and in vivo study of adipose tissue browning

    Type-2 Familial Partial Lipodystrophy is caused by LMNA mutations. Patients gradually lose subcutaneous fat from the limbs, while they accumulate adipose tissue in the face and neck. Several studies have demonstr...

    Camilla Pellegrini, Marta Columbaro, Elisa Schena in Experimental & Molecular Medicine (2019)

  9. No Access

    Article

    Brain functional imaging in obese and diabetic patients

    Obesity and type 2 diabetes are associated with greater risk of brain damage. Over the last decade, functional imaging techniques (functional magnetic resonance imaging, fMRI, positron emission tomography, PET...

    Maria Angela Guzzardi, Patricia Iozzo in Acta Diabetologica (2019)

  10. No Access

    Article

    Dynamic changes in p66Shc mRNA expression in peripheral blood mononuclear cells following resistance training intervention in old frail women born to obese mothers: a pilot study

    The p66Shc gerontogene may affect healthspan by promoting fat accumulation. We assessed changes of p66Shc-mRNA in peripheral tissues in relation to maternal obesity and the moderating effects of resistance-traini...

    Alessandra Berry, Marco Bucci, Carla Raggi in Aging Clinical and Experimental Research (2018)

  11. Article

    Nuclear receptors control pro-viral and antiviral metabolic responses to hepatitis C virus infection

    A metabolomics analysis finds that host glycolysis, fatty acid oxidation, the urea cycle, cholesterol biosynthesis and oxidative phosphorylation are modified by hepatitis C virus infection. These effects are m...

    Gahl Levy, Naomi Habib, Maria Angela Guzzardi, Daniel Kitsberg in Nature Chemical Biology (2016)

  12. Article

    Resistance training improves skeletal muscle insulin sensitivity in elderly offspring of overweight and obese mothers

    Maternal obesity predisposes offspring to adulthood morbidities, including type 2 diabetes. Type 2 diabetes and insulin resistance have been associated with shortened telomere length. First, we aimed to invest...

    Marco Bucci, Ville Huovinen, Maria Angela Guzzardi, Suvi Koskinen in Diabetologia (2016)

  13. Article

    Independent effects of circulating glucose, insulin and NEFA on cardiac triacylglycerol accumulation and myocardial insulin resistance in a swine model

    Cardiac steatosis and myocardial insulin resistance elevate the risk of cardiac complications in obesity and diabetes. We aimed to disentangle the effects of circulating glucose, insulin and NEFA on myocardial...

    Maria Angela Guzzardi, Leanne Hodson, Letizia Guiducci, Elena Sanguinetti in Diabetologia (2014)